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SUMMARY
The clinical features, parasitology and prophylactic history of 67 patients who
imported malaria to Northern Ireland between 1974 and 1983 are reported.
P. falciparum infections were encountered more frequently than anticipatedfrom
currentUnitedKingdom experience. The clinical implications ofthesefindings are
discussed.
INTRODUCTION
Malaria remains a major health problem for more tihan one thousand million of
the world's population, and areas where infected anopheles mosquitos may be
encountered are growing. Once endemic in the British Isles, malaria declined in
importance during the 18th and 19th centuries. The indigenous anopheles
mosquito prefers animal to human blood, and changes in animal husbandry and
marsh reclamation meant that, by the early 20th century, indigenous malaria had
almost disappeared.1 Thereafter in the British Isles malaria has been a disease of
importation, a trend strikingly illustrated by peaks in malaria incidence that
followed the return of those who served in malarial areas during two world wars
and the Korean conflict.
The situation changed radically during the decade surveyed with the explosive
growth in international travel. The incidence of malaria in the United Kingdom
increased from 540 cases (1973) to 2,053 cases (1980). These figures
constitute more than half of all malaria importation into Europe.2 Two groups
contribute to this excess of malaria importation - new immigrants and former
immigrants returning from a visit to their country of origin. Since the majority of
these patients acquire infection in Asia, the predominant parasite involved is
P. vivax. In the United Kingdom infection by P. vivaxand other relapsing malarias
accounted for more than two-thirds of isolates during the survey period. This
study was undertaken to investigate a clinical impression that the pattern of
malaria importation to Northern Ireland differed from that ofthe United Kingdom.
METHODS
A retrospective survey of hospital records for the period 1974- 1983 identified
63 malaria patients (59 in-patients, four out-patients). Laboratory records added
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four cases, giving a total of 67 patients with recognised malaria during this
decade. All but five patients initially presented to their family doctor. Most were
then referred to infectious disease consultants (40 cases), general physicians (14
cases), or consultant haematologists (three cases). For seven patients, the
diagnosis was made clinically on the basis offever following travel to an endemic
area which responded to specific anti-malarial therapy. In the remaining cases,
diagnosis was established by blood film examination in local haematological
laboratories. Further confirmation of this parasitological diagnosis was obtained
in 41 cases from the Public Health Laboratory Service, Malaria Reference
Laboratory (London School of Hygiene and Tropical Medicine) or from the
Liverpool School of Tropical Medicine.
RESULTS
There were 50 male and 17 female patients, mostly in the 18 -40 age range.
Europeans, of whom there were 43, formed the largest ethnic group. There were
18 patients of Indian extraction, four of African origin, one patient was of mixed
African/European descent and in one case there was no record of racial origin.
Reasons for travel are set out in Table I and compared with similar data for the
whole of the United Kingdom during the same period. The most readily identi-
fiable group among patients of local extraction were missionaries (14) and
employees of voluntary organisations (1 1), returning on furlough from malaria
endemic areas. Immigrants provided a much smaller number of malaria victims
than would be anticipated from the comparable United Kingdom experience.
TABLE I
Reasons for travel
Reasonsfor travel in 67 cases ofmalaria diagnosed in Northern Ireland compared
with the figures for the whole of the United Kingdom.
Percentage of Percentage of
Northern Ireland United Kingdom
Cases cases cases3
New immigrants 6 8.8% 23.3%
Former immigrants revisiting
country of origin 10 14.8% 28.6%
Air/sea crews/military 4 5.8% 1.8%
Foreign visitors 6.8%
Long-term residents overseas
returning home on furlough 14 20.8% 3.7%
Children visiting parents
living abroad 6 8.8% 1.3%
Voluntary service overseas
business 11 16.4% 5.4%
No record 16 23.8% 29.1%
67 100% 100%
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Northern Ireland malaria patients were most likely to have been infected in sub-
Saharan Africa (39 cases), almost equally divided between east, central and
western regions of that continent. As expected, the predominant parasite
demonstrated was P. falciparum. Twenty-two patients presented on return from
the Indian sub-continent and, where a parasitological diagnosis was made, all
showed P. vivax infection. (Table 11). Of the 56 patients for whom clinical data is
available, all presented to their doctor with a fever or rigor. Other common
symptoms were headache (22), myalgia (13) and symptoms referrable to the
gastrointestinal tract, including nausea (9), vomiting (12), abdominal pain (8)
and diarrhoea (7). Few had positive clinical signs. Hepatomegaly was present in
only 14, splenomegaly in nine; five were jaundiced and three anaemic.
TABLE II
Parasitological diagnosis and source ofinfection
Africa India Other Total
P. falciparum 27* - 27
P. vivax 2* 17 3 22
P. ovale 2 2
P. malariae 1 1
Parasites not specified 4 4 1 9
'Clinical' diagnosis without confirmation 5 1 1 7
* One mixed infection.
Ofthe patients infected with P. falciparum in whom the interval between arrival in
Northern Ireland and the onset of symptoms was recorded, three-quarters
presented within one month and the remainder within three months. In patients
with P. vivaxinfection, only a quarter developed symptoms within the first month
oftheir arrival, theremainder presenting within 12 months. In one caseofP. ovale
infection, the latent period was longer than a year. The single case of P. malariae
infection presented two months after return to this country.
Details of the malaria prophylaxis were recorded in only 45 of the cases.
Seventeen patients took no prophylaxis whatever, six patients took some form of
medication irregularly, six others had discontinued regular prophylaxis immed-
iately on return or before completing four weeks in this country. Sixteen patients
were recorded as taking full prophylaxis; proguanil in two cases, chloroquine
in two cases, pyrimethamine (Daraprim) in five cases, or pyrimethamine and
dapsone (Maloprim) in seven cases. All the patients were treated initially with
chloroquine. Haemolysis occurred in one case and methaemoglobinaemia
(following the use ofdapsone) in another. Quinine was required forthree cases of
P. falciparum infection - all acquired in Africa - which proved resistant to
chloroquine. There were nodeaths and thereis norecord ofany serious sequelae.
DISCUSSION
We located fewer malaria infections in Northern Ireland than overall United
Kingdom statistics led us to expect. This probably reflects the small proportion of
immigrants to our community. In the whole United Kingdom, more than half the
patients with malaria were immigrants, most acquiring their infection on the
© The Ulster Medical Society, 1986.
5960 The Ulster Medical Journal
Indian sub-continent where P. vivax infection dominates. The resulting illness
usually has a typical symptomatology, likely to be recognised as malaria,
especially if the patient is Indian. Even where diagnosis is delayed, little harm
ensues. In Northern Ireland most of those infected were of local origin and were
infected in Africa where P. falciparum infection is common. This has considerable
clinical significance. The resulting illness frequently follows a fulminant course
and can progress rapidly to death, yet the symptoms and clinical findings are
much less specific.
P. falciparum was responsible for almost all malaria deaths occurring in the
United Kingdom, the annual case mortality varying from 1.4% to 10% during
the survey period. In almost all instances, death from falciparum malaria was the
consequence of late diagnosis. In Northern Ireland, there were no deaths during
the survey period, but there is no room for complacency. Our current good
record will be maintained only by extreme clinical vigilance. The presenting
features of malaria, particularly the dangerous P. falciparum infections, mimic the
many simple locally acquired fevers and gastrointestinal upsets. It is esential that
both hospital doctors and family practitioners consider malaria as a possible
diagnosis in any febrile patient recently returned from a malaria endemic region.
Even completion of a full course of anti-malarial chemoprophylaxis does not
exclude this possible diagnosis.
Many ofthose infected failed to seek or did not receive adequate advice aboutthe
need for malaria prophylaxis. The family doctor is usually approached to provide
this and with the rapid spread of drug-resistance strains of P. falciparum, it is
essential that such prophylactic advice is constantly updated. The Public Health
Laboratory Service Malaria Reference Laboratory (London School of Hygiene
and Tropical Medicine) periodically publish such details.3 Together with the
Liverpool School of Tropical Medicine, they provide a telephone answering
service. The Medical Advisory Service for Travellers Abroad (MASTA) at the
London School of Hygiene and Tropical Medicine also include advice on malarial
prophylaxis within their comprehensive health brief. Whatever prophylactic
therapy is chosen, patients must be advised to start medication a week prior to
departure and to maintain drug cover throughout their stay in the malaria
endemic area and subsequently for four to six weeks after their last possible
mosquito contact. Prescriptions for drug prophylaxis must be supplemented by
emphatic advice on methods of avoiding mosquito bites including the use of
mosquito nets, repellent creams and sprays and suitable clothing for the period
between dusk and dawn.4 Such simple measures do much to reduce the risk of
malaria.
The authors wish to thank the doctors and medical records officers who helped by making available
patients' clinical notes.
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